- Cleveland Clinic Coordinating Center
- Baylor College of Medicine
- Cleveland Clinic Lutheran
- Yale School of Medicine
- Mount Sinai Hospital
Study Sponsor: Cleveland Clinic
Lead Principal Investigator
“This study will fill the evidence gap around ketamine versus ECT for treatment-resistant depression,”
Baylor College of Medicine
Dr. Mathew is a Professor of Psychiatry and Behavioral Sciences, the Chair for Research in Psychiatry, and the Director of the Mood and Anxiety Disorders Program at Baylor College of Medicine.
If you live in Houston and would like to see if you are eligible for the study, please contact Sidra Iqbal at (713) 689-9856 or email email@example.com. You may also contact Dr. Mathew at firstname.lastname@example.org.
Dr. Dale is the Medical Director for Adult and Geriatric Inpatient Services at the Cleveland Clinic.
If you live in Cleveland and would like to see if you are eligible for the study, please contact Kelly Bryant at (216) 363-2492 or email@example.com.
Yale School of Medicine
Dr. Sanacora is a Professor of Psychiatry and the Medical Director of the Yale Depression Research Program at Yale.
If you live in New Haven and would like to see if you are eligible for the study please contact Jane Wanyiri, RN by phone at (203) 764-9131 or by email at firstname.lastname@example.org.
Dr. Murrough is an Assistant Professor in Psychiatry and Director of the Mood and Anxiety Disorders Program at the Icahn School of Medicine at Mount Sinai.
If you live in New York City and would like to see if you are eligible for the study please contact Mora Grehl at (212) 241-8538 or email@example.com.